652 related articles for article (PubMed ID: 15755578)
1. Health economic research on vaccinations and immunisation practices--an introductory primer.
Szucs TD
Vaccine; 2005 Mar; 23(17-18):2095-103. PubMed ID: 15755578
[TBL] [Abstract][Full Text] [Related]
2. Economic evaluation of immunization strategies.
Ess SM; Szucs TD
Clin Infect Dis; 2002 Aug; 35(3):294-7. PubMed ID: 12115095
[TBL] [Abstract][Full Text] [Related]
3. WHO Guide for standardisation of economic evaluations of immunization programmes.
Walker DG; Hutubessy R; Beutels P
Vaccine; 2010 Mar; 28(11):2356-9. PubMed ID: 19567247
[TBL] [Abstract][Full Text] [Related]
4. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
5. Health economics in developing countries.
Abel-Smith B
J Trop Med Hyg; 1989 Aug; 92(4):229-41. PubMed ID: 2503621
[TBL] [Abstract][Full Text] [Related]
6. Cost-benefit comparisons of investments in improved water supply and cholera vaccination programs.
Jeuland M; Whittington D
Vaccine; 2009 May; 27(23):3109-20. PubMed ID: 19428925
[TBL] [Abstract][Full Text] [Related]
7. [Vaccination--value for money?].
Wisløff T; Abrahamsen TG; Bergsaker MA; Løvoll Ø; Kristiansen IS
Tidsskr Nor Laegeforen; 2006 Oct; 126(20):2670-3. PubMed ID: 17057767
[TBL] [Abstract][Full Text] [Related]
8. A cost-benefit analysis of typhoid fever immunization programmes in an Indian urban slum community.
Poulos C; Bahl R; Whittington D; Bhan MK; Clemens JD; Acosta CJ
J Health Popul Nutr; 2004 Sep; 22(3):311-21. PubMed ID: 15609784
[TBL] [Abstract][Full Text] [Related]
9. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
10. How to anticipate the assessment of the public health benefit of new medicines?
Massol J; Puech A; Boissel JP;
Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis in severe mental illness: outcome measures selection.
Stant AD; Buskens E; Jenner JA; Wiersma D; TenVergert EM
J Ment Health Policy Econ; 2007 Jun; 10(2):101-8. PubMed ID: 17603150
[TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.
Wisløff T; Abrahamsen TG; Bergsaker MA; Løvoll Ø; Møller P; Pedersen MK; Kristiansen IS
Vaccine; 2006 Jul; 24(29-30):5690-9. PubMed ID: 16735083
[TBL] [Abstract][Full Text] [Related]
13. Cost of depression in Europe.
Sobocki P; Jönsson B; Angst J; Rehnberg C
J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
[TBL] [Abstract][Full Text] [Related]
14. Retrospective cost-effectiveness analyses for polio vaccination in the United States.
Thompson KM; Tebbens RJ
Risk Anal; 2006 Dec; 26(6):1423-40. PubMed ID: 17184390
[TBL] [Abstract][Full Text] [Related]
15. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam.
Fischer TK; Anh DD; Antil L; Cat ND; Kilgore PE; Thiem VD; Rheingans R; Tho le H; Glass RI; Bresee JS
J Infect Dis; 2005 Nov; 192(10):1720-6. PubMed ID: 16235169
[TBL] [Abstract][Full Text] [Related]
16. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
Peny JM; Gleizes O; Covilard JP
Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
[TBL] [Abstract][Full Text] [Related]
17. [The contribution of social medicine to vaccination in Austria].
Kunze M
Wien Med Wochenschr; 1998; 148(8-9):191-7. PubMed ID: 9677675
[TBL] [Abstract][Full Text] [Related]
18. [Dengue fever: from disease to vaccination].
Teyssou R
Med Trop (Mars); 2009 Aug; 69(4):333-4. PubMed ID: 19725380
[TBL] [Abstract][Full Text] [Related]
19. [Vaccination: cost-effectiveness ratio].
Swennen B
Rev Med Brux; 2009 Sep; 30(4):451-7. PubMed ID: 19899394
[TBL] [Abstract][Full Text] [Related]
20. Do we fully understand the economic value of vaccines?
Drummond M; Chevat C; Lothgren M
Vaccine; 2007 Aug; 25(32):5945-57. PubMed ID: 17629362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
